Eastern Bank’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.1K Hold
325
– – ﹤0.01% 813
2026
Q2
$18.5K Hold
325
– – ﹤0.01% 789
2026
Q1
$9.7K Buy
+325
New +$9.7K ﹤0.01% 855

Other funds holding TVTX

Eastern Bank's TVTX Position: Q3 2026 in Review

Eastern Bank held its Travere Therapeutics (TVTX) position steady in Q3 2026 at 325 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #813.

Eastern Bank first reported a position in TVTX in Q1 2026 and has held it in 3 quarters since. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • Eastern Bank held 325 shares of Travere Therapeutics worth $19.1K as of Q3 2026.
  • Eastern Bank left its Travere Therapeutics share count unchanged in Q3 2026.
  • Travere Therapeutics made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #813 holding.
  • Eastern Bank first reported a position in Travere Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.